In the adipose tissue of our body, cells called "stem cells" are known to exist. The CAL(Cell-Assisted Lipotransfer) augmentation procedure is a treatment method which aims at improving, compared to the normal lipo-transplantation, the survival and efficiency of cells after transplantation by extracting Adipose-Derived Cells (ADCs) which contain Mesenchymal stem cells (*,P) and then, after mixing them with the aspirated fat itself, injecting them into the area the patient has requested.
In addition, we are able to perform safe cell processing because our clinic is fully equipped with Cell Processing Centers (CPCs), which ordinary medical institutes do not have,.
*,PAdipose-derived Mesenchymal Stem Cell
CELLPORT CLINIC YOKOHAMA is operated by a corporation.
In July 2005, Kanagawa prefecture was designated as a Special Zone with the purpose of promoting bio-related industries under the Law on Special Zones for Structural Reform. Biomaster Inc. is the first company in Japan which was authorized to establish a medical institute, such as a hospital (under Article 18 of the Law on Special Zones for Structural Reform), and began operating CELLPORT CLINIC YOKOHAMA.
For nearly 60 years since the Medical Care Law was first enacted in 1948, no corporation has been allowed to operate as a medical institute. CELLPORT CLINIC YOKOHAMA is the first medical institute established and operated by a corporation in accordance with the Law on Special Zones for Structural Reform with the view of promoting development and dissemination of advanced medical practices through utilizing a corporation's ability to raise funds and its enthusiasm for R&D.
